Related Experiment Video
Updated: Jul 24, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids
Ayan Chanda1, Anusi Sarkar1, Lili Deng1
1Department of Biochemistry and Molecular Biology, Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Abstract:
Protein post-translational modification by the small ubiquitin-like modifier (SUMO) regulates the stability, subcellular localization, and interactions of protein substrates with consequences on cellular responses including epithelial-mesenchymal transition (EMT). Transforming growth factor beta (TGFβ) is a potent inducer of EMT with implications for cancer invasion and metastasis. The transcriptional coregulator SnoN suppresses TGFβ-induced EMT-associated responses in a sumoylation-dependent manner, but the underlying mechanisms have remained largely unknown. Here, we find that sumoylation promotes the interaction of SnoN with the epigenetic regulators histone deacetylase 1 (HDAC1) and histone acetylase p300 in epithelial cells. In gain and loss of function studies, HDAC1 suppresses, whereas p300 promotes, TGFβ-induced morphogenetic changes associated with EMT-related events in three-dimensional multicellular organoids derived from mammary epithelial cells or carcinomas. These findings suggest that sumoylated SnoN acts via the regulation of histone acetylation to modulate EMT-related effects in breast cell organoids. Our study may facilitate the discovery of new biomarkers and therapeutics in breast cancer and other epithelial cell-derived cancers.
Insights
Sumoylation of SnoN protein enhances its interaction with epigenetic regulators, influencing transforming growth factor beta (TGFβ)-induced epithelial-mesenchymal transition (EMT). This mechanism impacts breast cancer progression and offers potential therapeutic targets.
Area of Science:
- Cell Biology
- Epigenetics
- Cancer Research
Background:
- Post-translational modification by SUMO regulates protein function and cellular processes like EMT.
- Transforming growth factor beta (TGFβ) drives EMT, a process critical for cancer invasion and metastasis.
- The transcriptional coregulator SnoN suppresses TGFβ-induced EMT, but its mechanism is unclear.
Purpose of the Study:
- To elucidate the sumoylation-dependent mechanism by which SnoN regulates TGFβ-induced EMT.
- To investigate the interaction of sumoylated SnoN with epigenetic regulators.
Main Methods:
- Investigated protein interactions using gain and loss of function studies in mammary epithelial and carcinoma organoids.
- Assessed the role of histone deacetylase 1 (HDAC1) and histone acetylase p300 in TGFβ-induced EMT.
Main Results:
- Sumoylation promotes SnoN interaction with HDAC1 and p300 in epithelial cells.
- HDAC1 suppresses TGFβ-induced EMT-related morphogenetic changes.
- p300 promotes TGFβ-induced EMT-related morphogenetic changes.
Conclusions:
- Sumoylated SnoN regulates EMT by modulating histone acetylation via HDAC1 and p300.
- Findings suggest a novel mechanism for controlling EMT in breast cancer.
- This research may lead to new biomarkers and therapeutics for epithelial cell-derived cancers.
Related Concept Videos
Inheritance of Chromatin Structures
Master Transcription Regulators
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Co-activators and Co-repressors
Epigenetic Regulation
X-chromosome...

